Herpes Zoster, also known as zoster or shingles, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide stripe either on the left or right side of the body or face. Two to four days before the rash occurs there may be tingling or local pain in the area. Otherwise there are typically few symptoms though some may have fever, headache, or feel tired. The rash usually heals within two to four weeks; however, some people develop ongoing nerve pain which can last for months or years, a condition called postherpetic neuralgia (PHN). In those with poor immune function the rash may occur widely. If the rash involves the eye, vision loss may occur.
This report contains market size and forecasts of Herpes Zoster Treatment in Global, including the following market information:
Global Herpes Zoster Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Herpes Zoster Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Herpes Zoster Treatment include Roche, Novartis, Merck, GlaxoSmithKline, Abbott Laboratories, Astellas Pharma, Bausch Health Companies, Teva Pharmaceutical and Foamix Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Herpes Zoster Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Herpes Zoster Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Herpes Zoster Treatment Market Segment Percentages, by Type, 2021 (%)
Oral
Topical
Others
Global Herpes Zoster Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Herpes Zoster Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Home Care Settings
Global Herpes Zoster Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Herpes Zoster Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Herpes Zoster Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Herpes Zoster Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Merck
GlaxoSmithKline
Abbott Laboratories
Astellas Pharma
Bausch Health Companies
Teva Pharmaceutical
Foamix Pharmaceuticals